Qtron Investments LLC Has $1.19 Million Stock Holdings in Danaher Corporation $DHR

Key Points

• Qtron Investments LLC has reduced its stake in Danaher Corporation (NYSE:DHR) by 27.6%, now holding 5,795 shares valued at approximately $1.19 million.
• Multiple institutional investors have increased their holdings in Danaher, with notable increases from GHP Investment Advisors Inc. (up 396%) and Sierra Ocean LLC (up 116.9%) during the first quarter.
• Danaher reported earnings of $1.80 per share for the last quarter, exceeding estimates, with revenue of $5.94 billion, up 3.4% year-over-year.

Qtron Investments LLC lessened its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 27.6% in the first quarter, according to its most recent filing with the SEC. The firm owned 5,795 shares of the conglomerate's stock after selling 2,209 shares during the period. Qtron Investments LLC's holdings in Danaher were worth $1,188,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth $27,000. GHP Investment Advisors Inc. boosted its position in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares in the last quarter. Sierra Ocean LLC boosted its position in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher during the first quarter worth $31,000. Finally, Dunhill Financial LLC boosted its position in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on DHR. Barclays reissued an "overweight" rating and set a $225.00 price target (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Robert W. Baird lifted their price target on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, The Goldman Sachs Group cut their price objective on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $247.61.

Danaher Trading Up 0.3%

Shares of NYSE:DHR opened at $210.84 on Monday. The stock has a market capitalization of $150.97 billion, a PE ratio of 44.86, a price-to-earnings-growth ratio of 2.94 and a beta of 0.73. The company's 50-day moving average price is $199.94 and its two-hundred day moving average price is $199.54. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the business earned $1.72 EPS. Danaher's revenue for the quarter was up 3.4% compared to the same quarter last year. On average, equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.